Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.006030566598999041,6.76044226044226,34.55204108614192,"['RPTOR', 'DEPTOR', 'ATG7', 'COASY']",0.6413119449361591,0,0,4
2,Autophagy WP4923,0.009055129766322284,9.272727272727273,43.62283939985336,"['RPTOR', 'DEPTOR', 'ATG7']",0.6413119449361591,0,0,3
3,Hematopoietic Stem Cell Differentiation WP2849,0.009055129766322284,9.272727272727273,43.62283939985336,"['SEC14L2', 'PIM1', 'ACVR1B']",0.6413119449361591,0,0,3
4,Oxidative Damage WP3941,0.012447737346477738,7.946608946608946,34.85554657998531,"['PCNA', 'BAD', 'TRAF3']",0.6413119449361591,0,0,3
5,Acetylcholine Synthesis WP528,0.014856647373038434,18.496644295302012,77.85807057363508,"['ACHE', 'CHKA']",0.6413119449361591,0,0,2
6,Transcription co-factors SKI and SKIL protein partners WP4533,0.014856647373038434,18.496644295302012,77.85807057363508,"['MERTK', 'STK3']",0.6413119449361591,0,0,2
7,Ectoderm Differentiation WP2858,0.019993120680251542,2.7789557766320527,10.872294959950194,"['GRAMD1B', 'GREB1', 'PIM1', 'ROR2', 'NR2F2', 'NF2', 'FGFR2']",0.7397454651693071,0,0,7
8,Kennedy pathway from sphingolipids WP3933,0.02392203267760912,12.328859060402685,46.023080701453246,"['CHKA', 'ETNK1']",0.7744758079375953,0,0,2
9,Parkinson's disease pathway WP2371,0.0390022656522769,4.6313131313131315,15.024607530291522,"['CASP6', 'CCNE1', 'UBE2J1']",0.7867093664842284,0,0,3
10,Fragile X Syndrome  WP4549,0.04225803441438664,2.537105751391466,8.027303091109442,"['GRIA1', 'RPTOR', 'DEPTOR', 'FMR1', 'AKAP5', 'DLGAP3']",0.7867093664842284,0,0,6
11,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.046221438459128975,4.274281274281274,13.140472300644312,"['RPTOR', 'DEPTOR', 'IGFBP5']",0.7867093664842284,0,0,3
12,Tryptophan catabolism leading to NAD+ production WP4210,0.04691107493012955,7.394630872483221,22.62388418841773,"['NAPRT', 'NAMPT']",0.7867093664842284,0,0,2
13,NAD+ biosynthetic pathways WP3645,0.04691107493012955,7.394630872483221,22.62388418841773,"['NAPRT', 'NAMPT']",0.7867093664842284,0,0,2
14,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.0515993710122829,inf,inf,['TRAF3'],0.7867093664842284,0,0,1
15,Valproic acid pathway WP3871,0.0515993710122829,inf,inf,['IVD'],0.7867093664842284,0,0,1
16,Serotonin and anxiety WP3947,0.06045673613386604,6.1610738255033555,17.28690898276514,"['FMR1', 'HTR2C']",0.7867093664842284,0,0,2
17,Hedgehog Signaling Pathway WP4249,0.06045673613386604,6.1610738255033555,17.28690898276514,"['ARRB2', 'KIF7']",0.7867093664842284,0,0,2
18,Hippo-Yap signaling pathway WP4537,0.06045673613386604,6.1610738255033555,17.28690898276514,"['NF2', 'STK3']",0.7867093664842284,0,0,2
19,Melatonin metabolism and effects WP3298,0.06045673613386604,6.1610738255033555,17.28690898276514,"['ACHE', 'APOE']",0.7867093664842284,0,0,2
20,Regulatory circuits of the STAT3 signaling pathway WP4538,0.062466351018133,3.703030303030303,10.268974244353657,"['RPTOR', 'DEPTOR', 'TRIM28']",0.7867093664842284,0,0,3
21,Globo Sphingolipid Metabolism WP1424,0.07514292853619878,5.279961649089166,13.666458774160278,"['ST6GAL1', 'ST6GAL2']",0.7867093664842284,0,0,2
22,Monoamine Transport WP727,0.07514292853619878,5.279961649089166,13.666458774160278,"['UNC13B', 'ACHE']",0.7867093664842284,0,0,2
23,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.0908167432629929,4.619127516778524,11.080878642872154,"['NF2', 'STK3']",0.7867093664842284,0,0,2
24,Oxidation by Cytochrome P450 WP43,0.0908167432629929,4.619127516778524,11.080878642872154,"['CYP4Z1', 'CYP4X1']",0.7867093664842284,0,0,2
25,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.0908167432629929,4.619127516778524,11.080878642872154,"['RPTOR', 'BAD']",0.7867093664842284,0,0,2
26,15q11.2 copy number variation syndrome WP4940,0.10054477894656069,18.438127090301002,42.355182163816714,['FMR1'],0.7867093664842284,0,0,1
27,Composition of Lipid Particles WP3601,0.10054477894656069,18.438127090301002,42.355182163816714,['APOE'],0.7867093664842284,0,0,1
28,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.10054477894656069,18.438127090301002,42.355182163816714,['APOE'],0.7867093664842284,0,0,1
29,NAD+ metabolism WP3644,0.10054477894656069,18.438127090301002,42.355182163816714,['NAMPT'],0.7867093664842284,0,0,1
30,DNA IR-double strand breaks and cellular response via ATM WP3959,0.10154904914728974,2.921318447634237,6.681678565866775,"['PCNA', 'TRIM28', 'STK3']",0.7867093664842284,0,0,3
31,Neural Crest Differentiation WP2064,0.10154904914728974,2.921318447634237,6.681678565866775,"['LHX2', 'MBP', 'FGFR2']",0.7867093664842284,0,0,3
32,Fas ligand pathway and stress induction of heat shock proteins WP314,0.10733792458983689,4.105145413870246,9.161753711111928,"['CASP6', 'RIPK2']",0.7867093664842284,0,0,2
33,3q29 copy number variation syndrome WP4906,0.1239569609158415,2.642135642135642,5.516305916566165,"['GRIA1', 'NF2', 'WDR34']",0.7867093664842284,0,0,3
34,Apoptosis WP254,0.1239569609158415,2.642135642135642,5.516305916566165,"['CASP6', 'TRAF3', 'BAD']",0.7867093664842284,0,0,3
35,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.13577466607532893,2.52157943067034,5.034985500671696,"['RPTOR', 'PFKFB2', 'BAD']",0.7867093664842284,0,0,3
36,Hippo-Merlin Signaling Dysregulation WP4541,0.13962553303743058,2.1154440154440155,4.164867570084526,"['PPP1R14A', 'NF2', 'FGFR2', 'STK3']",0.7867093664842284,0,0,4
37,Metapathway biotransformation Phase I and II WP702,0.13962553303743058,2.1154440154440155,4.164867570084526,"['CYP4Z1', 'CYP4X1', 'EPHX2', 'KCNAB3']",0.7867093664842284,0,0,4
38,15q13.3 copy number variation syndrome WP4942,0.14697220009056303,9.217391304347826,17.67445682282758,['OTUD7A'],0.7867093664842284,0,0,1
39,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.14697220009056303,9.217391304347826,17.67445682282758,['APOE'],0.7867093664842284,0,0,1
40,Apoptosis Modulation by HSP70 WP384,0.14697220009056303,9.217391304347826,17.67445682282758,['CASP6'],0.7867093664842284,0,0,1
41,Caloric restriction and aging WP4191,0.14697220009056303,9.217391304347826,17.67445682282758,['NAMPT'],0.7867093664842284,0,0,1
42,Cell Differentiation - Index WP2029,0.14697220009056303,9.217391304347826,17.67445682282758,['LEFTY1'],0.7867093664842284,0,0,1
43,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.14697220009056303,9.217391304347826,17.67445682282758,['EPHX2'],0.7867093664842284,0,0,1
44,Hedgehog Signaling Pathway Netpath WP47,0.14697220009056303,9.217391304347826,17.67445682282758,['KIF7'],0.7867093664842284,0,0,1
45,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.14697220009056303,9.217391304347826,17.67445682282758,['FURIN'],0.7867093664842284,0,0,1
46,SARS-CoV-2 and COVID-19 Pathway WP4846,0.14697220009056303,9.217391304347826,17.67445682282758,['FURIN'],0.7867093664842284,0,0,1
47,Head and Neck Squamous Cell Carcinoma WP4674,0.14796097950560963,2.4115063680281073,4.607922505755031,"['RPTOR', 'TRAF3', 'FGFR2']",0.7867093664842284,0,0,3
48,Retinoblastoma gene in cancer WP2446,0.16048539331391543,2.3106060606060606,4.227374743354126,"['PCNA', 'CCNE1', 'SAP30']",0.7867093664842284,0,0,3
49,Amyotrophic lateral sclerosis (ALS) WP2447,0.16075458280925456,3.077181208053691,5.624706931337535,"['GRIA1', 'BAD']",0.7867093664842284,0,0,2
50,Histone Modifications WP2369,0.16075458280925456,3.077181208053691,5.624706931337535,"['SETDB1', 'KMT5A']",0.7867093664842284,0,0,2
51,Monoamine GPCRs WP58,0.16075458280925456,3.077181208053691,5.624706931337535,"['HTR2C', 'HTR5A']",0.7867093664842284,0,0,2
52,Apoptosis Modulation and Signaling WP1772,0.17331756196819711,2.2177777777777776,3.8869433096928647,"['CASP6', 'TRAF3', 'BAD']",0.7867093664842284,0,0,3
53,AMP-activated protein kinase (AMPK) signaling WP1403,0.18642746781015143,2.132090132090132,3.581299571934925,"['RPTOR', 'CPT1B', 'PPARGC1B']",0.7867093664842284,0,0,3
54,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.1910107463504424,6.1438127090301,10.17062477195812,['EPHX2'],0.7867093664842284,0,0,1
55,Autosomal recessive Osteopetrosis pathways WP4788,0.1910107463504424,6.1438127090301,10.17062477195812,['OSTM1'],0.7867093664842284,0,0,1
56,Biogenic Amine Synthesis WP550,0.1910107463504424,6.1438127090301,10.17062477195812,['ACHE'],0.7867093664842284,0,0,1
57,Mammalian disorder of sexual development WP4842,0.1910107463504424,6.1438127090301,10.17062477195812,['FGFR2'],0.7867093664842284,0,0,1
58,Ras signaling WP4223,0.19599637408372184,1.6822804314329738,2.741543646633716,"['RASA4', 'BAD', 'RASGRF2', 'KSR2', 'FGFR2']",0.7867093664842284,0,0,5
59,Wnt Signaling Pathway WP363,0.1985234756107148,2.636625119846596,4.2630218429695415,"['ARRB2', 'ROR2']",0.7867093664842284,0,0,2
60,One-carbon metabolism and related pathways WP3940,0.1985234756107148,2.636625119846596,4.2630218429695415,"['CHKA', 'ETNK1']",0.7867093664842284,0,0,2
61,Photodynamic therapy-induced unfolded protein response WP3613,0.1985234756107148,2.636625119846596,4.2630218429695415,"['DNAJB9', 'PDIA6']",0.7867093664842284,0,0,2
62,MECP2 and Associated Rett Syndrome WP3584,0.19978556414726095,2.052749719416386,3.3059753195820325,"['GRIA1', 'RBFOX1', 'MBP']",0.7867093664842284,0,0,3
63,Development of ureteric collection system WP5053,0.2177867037973921,2.4604026845637583,3.7502420181124076,"['FAT4', 'FGFR2']",0.7867093664842284,0,0,2
64,Disorders of the Krebs cycle WP4236,0.23278294056414606,4.607023411371237,6.715422355272802,['DHTKD1'],0.7867093664842284,0,0,1
65,Glial Cell Differentiation WP2276,0.23278294056414606,4.607023411371237,6.715422355272802,['MBP'],0.7867093664842284,0,0,1
66,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.23278294056414606,4.607023411371237,6.715422355272802,['ATG7'],0.7867093664842284,0,0,1
67,ID signaling pathway WP53,0.23278294056414606,4.607023411371237,6.715422355272802,['CCNE1'],0.7867093664842284,0,0,1
68,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.23278294056414606,4.607023411371237,6.715422355272802,['FGFR2'],0.7867093664842284,0,0,1
69,"NAD metabolism, sirtuins and aging WP3630",0.23278294056414606,4.607023411371237,6.715422355272802,['NAMPT'],0.7867093664842284,0,0,1
70,Nanoparticle triggered autophagic cell death WP2509,0.23278294056414606,4.607023411371237,6.715422355272802,['ATG7'],0.7867093664842284,0,0,1
71,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.23720175086007636,2.3062080536912752,3.3182741524314143,"['CYLD', 'TRAF3']",0.7867093664842284,0,0,2
72,Small cell lung cancer WP4658,0.24106304177909993,1.8464646464646464,2.6269593356271677,"['TRAF3', 'CCNE1', 'COL4A4']",0.7867093664842284,0,0,3
73,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.24106304177909993,1.8464646464646464,2.6269593356271677,"['CCNE1', 'PSMC4', 'UBE2J1']",0.7867093664842284,0,0,3
74,Serotonin and anxiety-related events WP3944,0.27240504396077114,3.68494983277592,4.792148977550055,['HTR2C'],0.7867093664842284,0,0,1
75,BMP Signaling Pathway in Eyelid Development WP3927,0.27240504396077114,3.68494983277592,4.792148977550055,['FGFR2'],0.7867093664842284,0,0,1
76,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.27240504396077114,3.68494983277592,4.792148977550055,['FGFR2'],0.7867093664842284,0,0,1
77,Mitochondrial Gene Expression WP391,0.27240504396077114,3.68494983277592,4.792148977550055,['PPARGC1B'],0.7867093664842284,0,0,1
78,SARS coronavirus and innate immunity WP4912,0.27240504396077114,3.68494983277592,4.792148977550055,['TRAF3'],0.7867093664842284,0,0,1
79,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.27622695593365765,2.0492170022371363,2.6363841644539647,"['RPTOR', 'PIM1']",0.7867093664842284,0,0,2
80,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.2957225490030159,1.9410102437301306,2.3647979953184506,"['RIPK2', 'APOE']",0.7867093664842284,0,0,2
81,Senescence and Autophagy in Cancer WP615,0.297907265159965,1.6280451574569221,1.971518779980555,"['PCNA', 'IGFBP5', 'ATG7']",0.7867093664842284,0,0,3
82,Pathways Regulating Hippo Signaling WP4540,0.297907265159965,1.6280451574569221,1.971518779980555,"['NF2', 'FGFR2', 'STK3']",0.7867093664842284,0,0,3
83,Regulation of toll-like receptor signaling pathway WP1449,0.297907265159965,1.6280451574569221,1.971518779980555,"['CYLD', 'CUEDC2', 'TRAF3']",0.7867093664842284,0,0,3
84,Cell Differentiation - Index expanded WP2023,0.3099873735625106,3.0702341137123748,3.5959309977536362,['LEFTY1'],0.7867093664842284,0,0,1
85,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.3099873735625106,3.0702341137123748,3.5959309977536362,['TRAF3'],0.7867093664842284,0,0,1
86,Type II diabetes mellitus WP1584,0.3099873735625106,3.0702341137123748,3.5959309977536362,['PHKA2'],0.7867093664842284,0,0,1
87,Zinc homeostasis WP3529,0.3099873735625106,3.0702341137123748,3.5959309977536362,['SLC39A11'],0.7867093664842284,0,0,1
88,Differentiation of white and brown adipocyte WP2895,0.3099873735625106,3.0702341137123748,3.5959309977536362,['PPARGC1B'],0.7867093664842284,0,0,1
89,Glycerolipids and Glycerophospholipids WP4722,0.3099873735625106,3.0702341137123748,3.5959309977536362,['ETNK1'],0.7867093664842284,0,0,1
90,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.3099873735625106,3.0702341137123748,3.5959309977536362,['FGFR2'],0.7867093664842284,0,0,1
91,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.3099873735625106,3.0702341137123748,3.5959309977536362,['BAD'],0.7867093664842284,0,0,1
92,Immune response to tuberculosis WP4197,0.3099873735625106,3.0702341137123748,3.5959309977536362,['PTPN2'],0.7867093664842284,0,0,1
93,miRNAs involved in DNA damage response WP1545,0.3099873735625106,3.0702341137123748,3.5959309977536362,['CCNE1'],0.7867093664842284,0,0,1
94,miRNAs involvement in the immune response in sepsis WP4329,0.3099873735625106,3.0702341137123748,3.5959309977536362,['TRAF3'],0.7867093664842284,0,0,1
95,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.3099873735625106,3.0702341137123748,3.5959309977536362,['NAMPT'],0.7867093664842284,0,0,1
96,Nanomaterial induced apoptosis WP2507,0.3099873735625106,3.0702341137123748,3.5959309977536362,['CASP6'],0.7867093664842284,0,0,1
97,Prostaglandin Synthesis and Regulation WP98,0.3099873735625106,3.0702341137123748,3.5959309977536362,['PPARGC1B'],0.7867093664842284,0,0,1
98,"GPCRs, Class A Rhodopsin-like WP455",0.3122764586084422,1.5812409812409813,1.8403532455721971,"['MC1R', 'HTR2C', 'HTR5A']",0.7867093664842284,0,0,3
99,Endometrial cancer WP4155,0.31513989751295574,1.8436241610738255,2.1289040189291977,"['BAD', 'FGFR2']",0.7867093664842284,0,0,2
100,Pathways in clear cell renal cell carcinoma WP4018,0.3266640339292487,1.537037037037037,1.7196724740689688,"['RPTOR', 'TOX2', 'DEPTOR']",0.7867093664842284,0,0,3
101,22q11.2 copy number variation syndrome WP4657,0.3344352811989664,1.7555129434324066,1.9228342129095555,"['DGCR6L', 'FGFR2']",0.7867093664842284,0,0,2
102,Synaptic Vesicle Pathway WP2267,0.3344352811989664,1.7555129434324066,1.9228342129095555,"['UNC13B', 'UNC13C']",0.7867093664842284,0,0,2
103,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.3344352811989664,1.7555129434324066,1.9228342129095555,"['PCNA', 'COL4A4']",0.7867093664842284,0,0,2
104,Mesodermal commitment pathway WP2857,0.3410493873765063,1.4952224952224953,1.608452676184875,"['LEFTY1', 'TRIM28', 'ACVR2A']",0.7867093664842284,0,0,3
105,16p11.2 distal deletion syndrome WP4950,0.34563460462731965,2.631151457238414,2.795264577385191,['RAB4A'],0.7867093664842284,0,0,1
106,Airway smooth muscle cell contraction WP4962,0.34563460462731965,2.631151457238414,2.795264577385191,['PPP1R14A'],0.7867093664842284,0,0,1
107,Statin inhibition of cholesterol production WP430,0.34563460462731965,2.631151457238414,2.795264577385191,['APOE'],0.7867093664842284,0,0,1
108,Cell migration and invasion through p75NTR WP4561,0.34563460462731965,2.631151457238414,2.795264577385191,['EFNA3'],0.7867093664842284,0,0,1
109,Vitamin B12 metabolism WP1533,0.34563460462731965,2.631151457238414,2.795264577385191,['APOE'],0.7867093664842284,0,0,1
110,DNA Mismatch Repair WP531,0.34563460462731965,2.631151457238414,2.795264577385191,['PCNA'],0.7867093664842284,0,0,1
111,miRNA regulation of p53 pathway in prostate cancer WP3982,0.34563460462731965,2.631151457238414,2.795264577385191,['SESN3'],0.7867093664842284,0,0,1
112,MTHFR deficiency WP4288,0.34563460462731965,2.631151457238414,2.795264577385191,['CHKA'],0.7867093664842284,0,0,1
113,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.34563460462731965,2.631151457238414,2.795264577385191,['STK3'],0.7867093664842284,0,0,1
114,G1 to S cell cycle control WP45,0.3535696707533384,1.675411836485662,1.741883339779844,"['PCNA', 'CCNE1']",0.7867093664842284,0,0,2
115,Vitamin D Receptor Pathway WP2877,0.3554129739926237,1.4556087187666136,1.505790623526739,"['IGFBP5', 'CCNE1', 'CLEC16A']",0.7867093664842284,0,0,3
116,PI3K-Akt signaling pathway WP4172,0.3754786170514337,1.2299319727891156,1.2047844819324656,"['RPTOR', 'EFNA3', 'BAD', 'CCNE1', 'COL4A4', 'FGFR2']",0.7867093664842284,0,0,6
117,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.379446058196165,2.301839464882943,2.2305810324547597,['HTR2C'],0.7867093664842284,0,0,1
118,Angiogenesis WP1539,0.379446058196165,2.301839464882943,2.2305810324547597,['FGFR2'],0.7867093664842284,0,0,1
119,Toll-like Receptor Signaling related to MyD88 WP3858,0.379446058196165,2.301839464882943,2.2305810324547597,['TRAF3'],0.7867093664842284,0,0,1
120,GDNF/RET signaling axis WP4830,0.379446058196165,2.301839464882943,2.2305810324547597,['FAT4'],0.7867093664842284,0,0,1
121,IL-7 signaling pathway WP205,0.379446058196165,2.301839464882943,2.2305810324547597,['BAD'],0.7867093664842284,0,0,1
122,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.379446058196165,2.301839464882943,2.2305810324547597,['B4GALT2'],0.7867093664842284,0,0,1
123,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.379446058196165,2.301839464882943,2.2305810324547597,['MBP'],0.7867093664842284,0,0,1
124,TNF-alpha signaling pathway WP231,0.4096794544572477,1.4735570469798658,1.3149731963362823,"['BAD', 'KSR2']",0.7867093664842284,0,0,2
125,ErbB signaling pathway WP673,0.4096794544572477,1.4735570469798658,1.3149731963362823,"['BTC', 'BAD']",0.7867093664842284,0,0,2
126,7-oxo-C and 7beta-HC pathways WP5064,0.41151597369440235,2.0457079152731326,1.8163992809142113,['EPHX2'],0.7867093664842284,0,0,1
127,TLR4 Signaling and Tolerance WP3851,0.41151597369440235,2.0457079152731326,1.8163992809142113,['TRAF3'],0.7867093664842284,0,0,1
128,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.41151597369440235,2.0457079152731326,1.8163992809142113,['TRAF3'],0.7867093664842284,0,0,1
129,FOXA2 pathway WP5066,0.41151597369440235,2.0457079152731326,1.8163992809142113,['PPARGC1B'],0.7867093664842284,0,0,1
130,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.41151597369440235,2.0457079152731326,1.8163992809142113,['IFITM3'],0.7867093664842284,0,0,1
131,Imatinib and Chronic Myeloid Leukemia WP3640,0.41151597369440235,2.0457079152731326,1.8163992809142113,['PIM1'],0.7867093664842284,0,0,1
132,PKC-gamma calcium signaling pathway in ataxia WP4760,0.41151597369440235,2.0457079152731326,1.8163992809142113,['GRIA1'],0.7867093664842284,0,0,1
133,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.4129596577419042,1.1767260095527572,1.0407028039905832,"['PFKFB2', 'RPTOR', 'EFNA3', 'BAD', 'COL4A4', 'FGFR2']",0.7867093664842284,0,0,6
134,Corticotropin-releasing hormone signaling pathway WP2355,0.4278611325449343,1.4166236448115643,1.2026519826637,"['TRIM28', 'ARRB2']",0.7867093664842284,0,0,2
135,White fat cell differentiation WP4149,0.44193376841949716,1.8408026755852842,1.5031907272131966,['NR2F2'],0.7867093664842284,0,0,1
136,Fatty acid beta-oxidation WP143,0.44193376841949716,1.8408026755852842,1.5031907272131966,['CPT1B'],0.7867093664842284,0,0,1
137,Glycosylation and related congenital defects WP4521,0.44193376841949716,1.8408026755852842,1.5031907272131966,['MAGT1'],0.7867093664842284,0,0,1
138,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.44193376841949716,1.8408026755852842,1.5031907272131966,['TRAF3'],0.7867093664842284,0,0,1
139,IL17 signaling pathway WP2112,0.44193376841949716,1.8408026755852842,1.5031907272131966,['TRAF3'],0.7867093664842284,0,0,1
140,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.44193376841949716,1.8408026755852842,1.5031907272131966,['RIPK2'],0.7867093664842284,0,0,1
141,SARS-CoV-2 mitochondrial interactions WP5038,0.44193376841949716,1.8408026755852842,1.5031907272131966,['TRAF3'],0.7867093664842284,0,0,1
142,Proteasome Degradation WP183,0.44574510118435906,1.3639075316927667,1.102048213713894,"['PSMC4', 'RPN1']",0.7867093664842284,0,0,2
143,DNA IR-damage and cellular response via ATR WP4016,0.4633136324677972,1.3149568552253117,1.011663453424142,"['PCNA', 'TRIM28']",0.7867093664842284,0,0,2
144,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.4633136324677972,1.3149568552253117,1.011663453424142,"['BAD', 'FGFR2']",0.7867093664842284,0,0,2
145,Glioblastoma signaling pathways WP2261,0.4633136324677972,1.3149568552253117,1.011663453424142,"['CCNE1', 'FGFR2']",0.7867093664842284,0,0,2
146,Genes controlling nephrogenesis WP4823,0.4707842831375819,1.6731529340224993,1.26047860958075,['FGFR2'],0.7867093664842284,0,0,1
147,miRNA regulation of prostate cancer signaling pathways WP3981,0.4707842831375819,1.6731529340224993,1.26047860958075,['BAD'],0.7867093664842284,0,0,1
148,16p11.2 proximal deletion syndrome WP4949,0.48055160665636226,1.2693820874797501,0.930229411965331,"['UNC13B', 'PCNA']",0.7867093664842284,0,0,2
149,Alzheimer's disease WP2059,0.48055160665636226,1.2693820874797501,0.930229411965331,"['BAD', 'APOE']",0.7867093664842284,0,0,2
150,Integrated breast cancer pathway WP1984,0.4942906073721943,1.1502525252525253,0.8105043471238486,"['BAD', 'DCAKD', 'DHTKD1']",0.7867093664842284,0,0,3
151,Splicing factor NOVA regulated synaptic proteins WP4148,0.4981480158432952,1.5334448160535117,1.0685933268047818,['NTNG1'],0.7867093664842284,0,0,1
152,Cardiac Progenitor Differentiation WP2406,0.4981480158432952,1.5334448160535117,1.0685933268047818,['ROR2'],0.7867093664842284,0,0,1
153,Type 2 papillary renal cell carcinoma WP4241,0.4981480158432952,1.5334448160535117,1.0685933268047818,['COL21A1'],0.7867093664842284,0,0,1
154,Complement system WP2806,0.4981480158432952,1.5334448160535117,1.0685933268047818,['ARRB2'],0.7867093664842284,0,0,1
155,Differentiation Pathway WP2848,0.4981480158432952,1.5334448160535117,1.0685933268047818,['LEFTY1'],0.7867093664842284,0,0,1
156,DNA Replication WP466,0.4981480158432952,1.5334448160535117,1.0685933268047818,['PCNA'],0.7867093664842284,0,0,1
157,Integrated Cancer Pathway WP1971,0.4981480158432952,1.5334448160535117,1.0685933268047818,['BAD'],0.7867093664842284,0,0,1
158,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.4981480158432952,1.5334448160535117,1.0685933268047818,['RAB4A'],0.7867093664842284,0,0,1
159,Intraflagellar transport proteins binding to dynein WP4532,0.4981480158432952,1.5334448160535117,1.0685933268047818,['WDR34'],0.7867093664842284,0,0,1
160,MAPK Cascade WP422,0.4981480158432952,1.5334448160535117,1.0685933268047818,['MBP'],0.7867093664842284,0,0,1
161,Oxysterols derived from cholesterol WP4545,0.4981480158432952,1.5334448160535117,1.0685933268047818,['EPHX2'],0.7867093664842284,0,0,1
162,Peptide GPCRs WP24,0.4981480158432952,1.5334448160535117,1.0685933268047818,['MC1R'],0.7867093664842284,0,0,1
163,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.4981480158432952,1.5334448160535117,1.0685933268047818,['CCNE1'],0.7867093664842284,0,0,1
164,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.4981480158432952,1.5334448160535117,1.0685933268047818,['TRAF3'],0.7867093664842284,0,0,1
165,Hepatitis B infection WP4666,0.5074166698410641,1.1265718408575551,0.7642919989113413,"['PCNA', 'TRAF3', 'BAD']",0.7964904090232461,0,0,3
166,CAMKK2  Pathway WP4874,0.5241013430421333,1.4152302546951376,0.9143381087108804,['RPTOR'],0.8074865522017656,0,0,1
167,NO/cGMP/PKG mediated Neuroprotection WP4008,0.5241013430421333,1.4152302546951376,0.9143381087108804,['BAD'],0.8074865522017656,0,0,1
168,Nuclear receptors WP170,0.5241013430421333,1.4152302546951376,0.9143381087108804,['NR2F2'],0.8074865522017656,0,0,1
169,Thermogenesis WP4321,0.5301655895820889,1.149748322147651,0.7295910650883112,"['RPTOR', 'CPT1B']",0.8074865522017656,0,0,2
170,ATM Signaling Pathway WP2516,0.5487167304537094,1.3139034878165312,0.7885693248160989,['CCNE1'],0.8074865522017656,0,0,1
171,Target Of Rapamycin (TOR) Signaling WP1471,0.5487167304537094,1.3139034878165312,0.7885693248160989,['RPTOR'],0.8074865522017656,0,0,1
172,Copper homeostasis WP3286,0.5487167304537094,1.3139034878165312,0.7885693248160989,['COMMD1'],0.8074865522017656,0,0,1
173,Energy Metabolism WP1541,0.5487167304537094,1.3139034878165312,0.7885693248160989,['PPARGC1B'],0.8074865522017656,0,0,1
174,Glycogen Synthesis and Degradation WP500,0.5487167304537094,1.3139034878165312,0.7885693248160989,['PHKA2'],0.8074865522017656,0,0,1
175,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.5487167304537094,1.3139034878165312,0.7885693248160989,['ARRB2'],0.8074865522017656,0,0,1
176,Prader-Willi and Angelman Syndrome WP3998,0.5487167304537094,1.3139034878165312,0.7885693248160989,['HTR2C'],0.8074865522017656,0,0,1
177,MAPK Signaling Pathway WP382,0.5570998721678221,1.0213963963963963,0.5975278733488528,"['RASGRF2', 'ARRB2', 'FGFR2', 'STK3']",0.8094362454426526,0,0,4
178,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.5720629322580871,1.2260869565217392,0.6847772555094637,['RPTOR'],0.8094362454426526,0,0,1
179,TGF-beta Receptor Signaling WP560,0.5720629322580871,1.2260869565217392,0.6847772555094637,['LEFTY1'],0.8094362454426526,0,0,1
180,Disruption of postsynaptic signaling by CNV WP4875,0.5720629322580871,1.2260869565217392,0.6847772555094637,['FMR1'],0.8094362454426526,0,0,1
181,IL-3 signaling pathway WP286,0.5720629322580871,1.2260869565217392,0.6847772555094637,['BAD'],0.8094362454426526,0,0,1
182,Ebola Virus Pathway on Host WP4217,0.5911445507238585,1.0212527964205818,0.536867187349977,"['DAB2IP', 'MERTK']",0.8094362454426526,0,0,2
183,Common Pathways Underlying Drug Addiction WP2636,0.5942051808265775,1.149247491638796,0.59821848292012,['GRIA1'],0.8094362454426526,0,0,1
184,IL-6 signaling pathway WP364,0.5942051808265775,1.149247491638796,0.59821848292012,['BAD'],0.8094362454426526,0,0,1
185,IL-18 signaling pathway WP4754,0.5982252529396973,0.966927453769559,0.49679564410270094,"['RPTOR', 'LARS2', 'PHF20', 'BAD']",0.8094362454426526,0,0,4
186,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.6054407844750652,0.9934699800471612,0.49852176252152447,"['RPTOR', 'SESN3']",0.8094362454426526,0,0,2
187,ATM Signaling Network in Development and Disease  WP3878,0.6152053663891758,1.081447963800905,0.5253664884218804,['TRIM28'],0.8094362454426526,0,0,1
188,Base Excision Repair WP4752,0.6152053663891758,1.081447963800905,0.5253664884218804,['PCNA'],0.8094362454426526,0,0,1
189,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.6152053663891758,1.081447963800905,0.5253664884218804,['LEFTY1'],0.8094362454426526,0,0,1
190,Cytosolic DNA-sensing pathway WP4655,0.6152053663891758,1.081447963800905,0.5253664884218804,['CYLD'],0.8094362454426526,0,0,1
191,Interferon type I signaling pathways WP585,0.6152053663891758,1.081447963800905,0.5253664884218804,['RPTOR'],0.8094362454426526,0,0,1
192,Kit receptor signaling pathway WP304,0.6152053663891758,1.081447963800905,0.5253664884218804,['BAD'],0.8094362454426526,0,0,1
193,Nephrotic syndrome WP4758,0.6152053663891758,1.081447963800905,0.5253664884218804,['COL4A4'],0.8094362454426526,0,0,1
194,Cell cycle WP179,0.6328916450355374,0.9421786267423852,0.4310053114477574,"['PCNA', 'CCNE1']",0.8094362454426526,0,0,2
195,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.635122207887139,1.0211817168338908,0.4635530281387193,['MBP'],0.8094362454426526,0,0,1
196,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.635122207887139,1.0211817168338908,0.4635530281387193,['GRIA1'],0.8094362454426526,0,0,1
197,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.635122207887139,1.0211817168338908,0.4635530281387193,['ROR2'],0.8094362454426526,0,0,1
198,Notch Signaling Pathway Netpath WP61,0.635122207887139,1.0211817168338908,0.4635530281387193,['SAP30'],0.8094362454426526,0,0,1
199,PPAR signaling pathway WP3942,0.635122207887139,1.0211817168338908,0.4635530281387193,['CPT1B'],0.8094362454426526,0,0,1
200,RANKL/RANK signaling pathway WP2018,0.635122207887139,1.0211817168338908,0.4635530281387193,['TRAF3'],0.8094362454426526,0,0,1
201,Calcium Regulation in the Cardiac Cell WP536,0.6387484884031234,0.9181818181818182,0.41156995363526344,"['SLC8A3', 'GRK4', 'ARRB2']",0.8094362454426526,0,0,3
202,VEGFA-VEGFR2 Signaling Pathway WP3888,0.6445236115385579,0.9167808219178082,0.4026903120068413,"['INPP4B', 'RAB4A', 'RCN1', 'DNAJB9', 'PTPN9', 'ARRB2', 'WASF1', 'PDIA6']",0.8094362454426526,0,0,8
203,Gastrin signaling pathway WP4659,0.646049400840632,0.9184563758389261,0.4012545842825551,"['BAD', 'ARRB2']",0.8094362454426526,0,0,2
204,Cardiac Hypertrophic Response WP2795,0.6540114147183652,0.9672592853370885,0.41072776879370826,['FGFR2'],0.8094362454426526,0,0,1
205,Ferroptosis WP4313,0.6540114147183652,0.9672592853370885,0.41072776879370826,['ATG7'],0.8094362454426526,0,0,1
206,IL-4 signaling pathway WP395,0.6540114147183652,0.9672592853370885,0.41072776879370826,['BAD'],0.8094362454426526,0,0,1
207,MET in type 1 papillary renal cell carcinoma WP4205,0.6540114147183652,0.9672592853370885,0.41072776879370826,['BAD'],0.8094362454426526,0,0,1
208,Nucleotide Excision Repair WP4753,0.6540114147183652,0.9672592853370885,0.41072776879370826,['PCNA'],0.8094362454426526,0,0,1
209,Phosphodiesterases in neuronal function WP4222,0.6540114147183652,0.9672592853370885,0.41072776879370826,['GRIA1'],0.8094362454426526,0,0,1
210,Adipogenesis WP236,0.6588321924083773,0.8958913079063676,0.37384327358442565,"['BMP3', 'NAMPT']",0.8094362454426526,0,0,2
211,Ciliary landscape WP4352,0.6644354568336549,0.8842396613480951,0.3614926795590065,"['PSMC4', 'TNKS1BP1', 'WDR34', 'SPATA7']",0.8094362454426526,0,0,4
212,Ciliopathies WP4803,0.6700186222007406,0.873977873977874,0.34998424093899333,"['KIF7', 'WDR34', 'SPATA7']",0.8094362454426526,0,0,3
213,Myometrial relaxation and contraction pathways WP289,0.6700186222007406,0.873977873977874,0.34998424093899333,"['IGFBP5', 'GRK4', 'ARRB2']",0.8094362454426526,0,0,3
214,Proximal tubule transport WP4917,0.6719258408114683,0.9187290969899665,0.3652933961302531,['SLC13A3'],0.8094362454426526,0,0,1
215,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.6719258408114683,0.9187290969899665,0.3652933961302531,['BAD'],0.8094362454426526,0,0,1
216,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.6889156300919984,0.8748208313425705,0.32599014486699035,['BAD'],0.8222541391420627,0,0,1
217,DNA damage response WP707,0.6889156300919984,0.8748208313425705,0.32599014486699035,['CCNE1'],0.8222541391420627,0,0,1
218,Chemokine signaling pathway WP3929,0.6949691589018648,0.8343502135448444,0.3036098720489037,"['GRK4', 'ARRB2']",0.8240089041789752,0,0,2
219,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.7050283554938244,0.8349042262085741,0.2918134345179484,['PPP1R14A'],0.8240089041789752,0,0,1
220,Eukaryotic Transcription Initiation WP405,0.7050283554938244,0.8349042262085741,0.2918134345179484,['POLR1B'],0.8240089041789752,0,0,1
221,miRNA regulation of DNA damage response WP1530,0.7050283554938244,0.8349042262085741,0.2918134345179484,['CCNE1'],0.8240089041789752,0,0,1
222,Regulation of Actin Cytoskeleton WP51,0.7062933464391216,0.8156599552572706,0.28362505036940405,"['WASF1', 'FGFR2']",0.8240089041789752,0,0,2
223,Acute viral myocarditis WP4298,0.7203091499110709,0.7984586302166642,0.26195414284133184,['CASP6'],0.8254870346325989,0,0,1
224,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.7203091499110709,0.7984586302166642,0.26195414284133184,['CCNE1'],0.8254870346325989,0,0,1
225,Toll-like Receptor Signaling Pathway WP75,0.7203091499110709,0.7984586302166642,0.26195414284133184,['TRAF3'],0.8254870346325989,0,0,1
226,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.7203091499110709,0.7984586302166642,0.26195414284133184,['ROR2'],0.8254870346325989,0,0,1
227,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.727892625888289,0.7806654291018135,0.2479406936249194,"['GRIA1', 'BAD']",0.8305030401104266,0,0,2
228,Mitochondrial CIV Assembly WP4922,0.7348008312545534,0.7650501672240803,0.2357546420179711,['SMIM20'],0.8347079618198656,0,0,1
229,T-cell receptor (TCR) signaling pathway WP69,0.7485440206072613,0.734314381270903,0.21267599733149656,['RIPK2'],0.8429256579881769,0,0,1
230,Non-small cell lung cancer WP4255,0.7485440206072613,0.734314381270903,0.21267599733149656,['BAD'],0.8429256579881769,0,0,1
231,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.7615772546886832,0.7059428865448932,0.192273189119664,['FGFR2'],0.8538896491964023,0,0,1
232,Wnt signaling WP428,0.7739370925464041,0.6796729840208101,0.17417618279648178,['ROR2'],0.8566226793569174,0,0,1
233,Endochondral Ossification with Skeletal Dysplasias WP4808,0.7739370925464041,0.6796729840208101,0.17417618279648178,['SLC38A2'],0.8566226793569174,0,0,1
234,Endochondral Ossification WP474,0.7739370925464041,0.6796729840208101,0.17417618279648178,['SLC38A2'],0.8566226793569174,0,0,1
235,Melanoma WP4685,0.7856582164183203,0.65527950310559,0.15807531577703796,['BAD'],0.8658956512865743,0,0,1
236,ESC Pluripotency Pathways WP3931,0.7967735280812562,0.6325683312190059,0.14370990731771918,['FGFR2'],0.8676115691144699,0,0,1
237,Leptin signaling pathway WP2034,0.7967735280812562,0.6325683312190059,0.14370990731771918,['BAD'],0.8676115691144699,0,0,1
238,Amino Acid metabolism WP3925,0.8073142399868234,0.611371237458194,0.1308593019734626,['LARS2'],0.8676115691144699,0,0,1
239,Spinal Cord Injury WP2431,0.8073142399868234,0.611371237458194,0.1308593019734626,['MBP'],0.8676115691144699,0,0,1
240,Osteoblast differentiation WP4787,0.8073142399868234,0.611371237458194,0.1308593019734626,['FGFR2'],0.8676115691144699,0,0,1
241,Pancreatic adenocarcinoma pathway WP4263,0.8073142399868234,0.611371237458194,0.1308593019734626,['BAD'],0.8676115691144699,0,0,1
242,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.8267887805943156,0.5729515050167224,0.10897882596061512,['PPARGC1B'],0.8812275480408548,0,0,1
243,Integrin-mediated Cell Adhesion WP185,0.8267887805943156,0.5729515050167224,0.10897882596061512,['GIT2'],0.8812275480408548,0,0,1
244,Androgen receptor signaling pathway WP138,0.8443009251840926,0.5390517410977769,0.09123251350176288,['CCNE1'],0.8889184537507315,0,0,1
245,DNA damage response (only ATM dependent) WP710,0.8443009251840926,0.5390517410977769,0.09123251350176288,['BAD'],0.8889184537507315,0,0,1
246,G Protein Signaling Pathways WP35,0.8443009251840926,0.5390517410977769,0.09123251350176288,['AKAP5'],0.8889184537507315,0,0,1
247,Focal Adhesion WP306,0.8505214122516312,0.5901710326910586,0.09555204908520251,"['BAD', 'COL4A4']",0.8901908367438078,0,0,2
248,Genes related to primary cilium development (based on CRISPR) WP4536,0.8523835039091286,0.5235547061634018,0.08362149352265076,['WDR34'],0.8901908367438078,0,0,1
249,Pyrimidine metabolism WP4022,0.8742068808722399,0.48195740186586866,0.06479349788959402,['POLR1B'],0.9093155909474303,0,0,1
250,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.8928130303604396,0.44644750795334043,0.05061736686376595,['COL4A4'],0.9249542994534155,0,0,1
251,DNA Repair Pathways Full Network WP4946,0.89838398383453,0.43573817486860966,0.04669270199344875,['PCNA'],0.9270177363073436,0,0,1
252,NRF2 pathway WP2884,0.9036663007197311,0.42552695029944776,0.04310380481701011,['SLC39A11'],0.9287681424063902,0,0,1
253,EGF/EGFR signaling pathway WP437,0.9179267048683497,0.3975570743056565,0.03404588687605756,['PCNA'],0.9396957176320261,0,0,1
254,7q11.23 copy number variation syndrome WP4932,0.9221960666969159,0.38902725396712445,0.03151020557284006,['PCNA'],0.9403495325767764,0,0,1
255,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.933720987523313,0.3654849498327759,0.025064085791726757,['PPARGC1B'],0.9481535918474474,0,0,1
256,Insulin Signaling WP481,0.9371711178106044,0.35825300019673423,0.023246818775137398,['RAB4A'],0.9481535918474474,0,0,1
257,mRNA Processing WP411,0.9544201088715838,0.32019010737546205,0.01493729717089825,['HNRNPA2B1'],0.9618475027149423,0,0,1
258,Circadian rhythm related genes WP3594,0.959047671641078,0.30922283317272264,0.012929996795188076,['NAMPT'],0.9627649106784465,0,0,1
259,Nuclear Receptors Meta-Pathway WP2882,0.9930369437543797,0.19710629635015267,0.0013772627910691045,['SLC39A11'],0.9930369437543797,0,0,1
